Literature DB >> 29959727

Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-κB/MAPKs Pathway.

Huatuo Zhu1, Shujun Huang1, Min Yue1, Wenguo Chen1, Chao Lu1, Xinhe Lou1, Chunxiao Li1, Guodong Shan1, Hongtan Chen1, Xiaowei Xu1, Guoqiang Xu2, Lihua Chen3.   

Abstract

BACKGROUND: Ulcerative colitis (UC) is an idiopathic colonic mucosal disease, and its pathogenesis has not been fully understood. Up-frameshift protein 1 (UPF1) is a potential molecule for UC predicted by a computational approach. AIM: The present study aimed to validate the underlying mechanism of UPF1 in UC.
METHODS: UPF1 expression was detected by qRT-PCR, western blotting, and immunohistochemistry in dextran sulfate sodium-induced colitis in mice. To simulate the intestinal inflammation microenvironment, NCM460 human colonic epithelial cells were exposed to a mixture of inflammatory mediators. The potential mechanism involving TNFR1-NF-κB/MAPKs pathway activation was addressed by western blotting, reporter gene assays, and siRNA (siUPF1) or UPF1-expressing plasmid pENTER-transfected cells.
RESULTS: UPF1 was downregulated in colonic epithelial cells of colitic mice, and in vitro, contrary to the mRNA levels of the associated cytokines enhanced in the UPF1 dysregulation group within stimulatory factors, most relevant cytokines were significantly decreased in UPF1 overexpression group. Mechanistically, the increased expression of tumor necrosis factor receptor 1 (TNFR1) was found in NCM460 cells pre-treated with siUPF1, with the activation of IKK/NF-κB and MAPKs pathways, including JNK/AP-1 and P38, but not the ERK1/2 pathway. Moreover, the repression of TNFR1 required the interaction of UPF1 with the promoter.
CONCLUSION: UPF1, which negatively regulated the transcription of TNFR1, is a novel factor regulating intestinal inflammation. The downregulation of UPF1 activated the TNFR1-dependent NF-κB/MAPKs pathway, and promoting inflammatory responses in colon might act as a causal role in UC.

Entities:  

Keywords:  NF-κB/MAPKs pathway; Tumor necrosis factor receptor 1 (TNFR1); Ulcerative colitis (UC); Up-frameshift mutant 1 (UPF1)

Mesh:

Substances:

Year:  2018        PMID: 29959727     DOI: 10.1007/s10620-018-5171-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  35 in total

Review 1.  How do pleiotropic kinase hubs mediate specific signaling by TNFR superfamily members?

Authors:  Bärbel Schröfelbauer; Alexander Hoffmann
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 2.  IBD pathogenesis in 2014: Molecular pathways controlling barrier function in IBD.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

3.  Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis.

Authors:  Basilia Zingarelli; Paul W Hake; Timothy J Burroughs; Giovanna Piraino; Michael O'connor; Alvin Denenberg
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

Review 4.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

5.  Mammalian orthologues of a yeast regulator of nonsense transcript stability.

Authors:  H A Perlick; S M Medghalchi; F A Spencer; R J Kendzior; H C Dietz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors.

Authors:  JingWei Lu; Terra-Dawn Plank; Fang Su; XiuJuan Shi; Chen Liu; Yuan Ji; ShuaiJun Li; Andrew Huynh; Chao Shi; Bo Zhu; Guang Yang; YanMing Wu; Miles F Wilkinson; YanJun Lu
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

7.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

8.  TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality.

Authors:  Emiko Mizoguchi; Yuriko Hachiya; Mayumi Kawada; Katsuya Nagatani; Atsuhiro Ogawa; Ken Sugimoto; Atsushi Mizoguchi; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2007-12-04       Impact factor: 22.682

9.  Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis.

Authors:  Huatuo Zhu; Xingyong Wan; Jing Li; Lu Han; Xiaochen Bo; Wenguo Chen; Chao Lu; Zhe Shen; Chenfu Xu; Lihua Chen; Chaohui Yu; Guoqiang Xu
Journal:  Sci Rep       Date:  2015-07-17       Impact factor: 4.379

Review 10.  The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.

Authors:  Chengxin Luo; Hu Zhang
Journal:  Mediators Inflamm       Date:  2017-08-09       Impact factor: 4.711

View more
  1 in total

1.  Tonifying-Qi-and-Detoxification Decoction attenuated injuries of colon and lung tissues in ulcerative colitis rat model via regulating NF-κB and p38MAPK pathway.

Authors:  Xin Yan; Xue Yu; Chunhua Jiang; Ying Cao; Liang Zhu; Chenguang Du; Yongsen Jia
Journal:  Ann Transl Med       Date:  2022-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.